Advance in sunscreens to prevent skin cancer

Expert Review of Dermatology

Volumn 6, Issue 5, 2011, Pages 479-491

  Osterwalder, Uli ^a   Herzog, Bernd ^a   Wang, Steven Q ^b  

^a BASF SE   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

compliance; ideal sunscreen; photoaging; prevention; skin cancer; spectral homeostasis; SPF; sun protection factor; UV filters; UVA protection

Indexed keywords

3 (4 METHYLBENZYLIDENE)CAMPHOR; 4 DIMETHYLAMINOBENZOIC ACID 2 ETHYLHEXYL ESTER; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; AMILOXATE; AVOBENZONE; BEMOTRIZINOL; BENZYLIDENE MALONATE POLYSILOXANE; BIS ETHYLHEXYLOXYPHENOL METHOXYPHENYLTRIAZINE; BISOCTRIZOLE; DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOIC ACID; DIETHYLHEXYL BUTAMIDO TRIAZONE; DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE; ECAMSULE; ENSULIZOLE; ETHYLHEXYL TRIAZONE; EUSOLEX 6007; EUSOLEX HMS; EUSOLEX T2000; HOMOSALATE; MERADIMATE; MEROXYL SX; METHYLENE BIS BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL; NEO HELIOPAN AP; NEO HELIOPAN E1000; NEO HELIOPAN OS; OCTISALATE; OCTOCRYLENE; OXYBENZONE; PARSOL SLX; SILICONE; SULISOBENZONE; SUNSCREEN; TEREPHTHALIDINE DICAMPHOR SULFONIC ACID; TINOSORB A2B; TITANIUM DIOXIDE; TRIS BIPHENYL TRIAZINE; UNCLASSIFIED DRUG; UVASORB HEB; UVINUL A PLUS; UVINUL M40; UVINUL MC 80; UVINUL MS40; UVINUL N 539 T; UVINUL T 150; ZINC OXIDE;

BASAL CELL CARCINOMA; BEHAVIOR CHANGE; COMPUTER MODEL; DRUG EFFICACY; DRUG LABELING; DRUG STRUCTURE; FOOD AND DRUG ADMINISTRATION; HUMAN; MELANOMA; PATIENT COMPLIANCE; PHOTOAGING; PRIORITY JOURNAL; REFLECTOMETRY; REVIEW; SKIN CANCER; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; STANDARD; SUNBURN; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 80053487915     PISSN: 17469872     EISSN: 17469880     Source Type: Journal    
DOI: 10.1586/edm.11.50     Document Type: Review

References (46)

1. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354, 723-729 (1999). (Pubitemid 29405786)
2. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J. Clin. Oncol. 29, 257-263 (2011).
3. Herzog B, Osterwalder U. In silico determination of topical sun protection. Cosmetic Science Techinology 62-70 (2011).
4. Stanfield J, Osterwalder U, Herzog B. In vitro measurments of sunscreen protection. Photochem. Photobiol. Sci. 9, 489-494 (2010).
5. European commission recommendation on the efficacy of sunscreen products and the claims made relating thereto. J. Eur. Union 245, 39-43 (2006).
6. Australian/New Zealand Standard. Sunscreen products-evaluation and classification. Standards Australia, Homebush, New South Wales, Australia and Standards New Zealand, Wellington, New Zealand, 2604 (1998).
7. Food and Drug Administration. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use, final rule. Fed. Regist. 76(117), 35620-35665 (2011).
8. Cole C, Vollhardt J, Mendrok C. Formulation and stability of sunscreen products, In: Clinical Guide To Sunscreens and Photoprotection. Lim HW, Draelos ZD (Eds). Informa Healthcare, New York, NY, USA, 39-51 (2009).
9. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol. Biomarkers Prev. 15, 2546-2548 (2006). (Pubitemid 46048320)
10. Seite S, Fourtanier A, Moyal, Young AR. Photodamage to human skin by suberythemal exposure to solar ultraviolet radiation can be attenuated by sunscreens: a review. Br. J. Dermatol. 163, 903-914 (2010).
11. Osterwalder U, Champ S, Flösser-Müller H, Herzog B. Evolution of UVA protection. Cosmetic Science Techinology 1-10 (2010).
12. Herzog, B, Hueglin D, Osterwalder U, New sunscreen actives. In: Sunscreens: Regulations and Commercial Development. Shaath N (Ed.). Taylor and Francis Group, Boca Raton, FL, USA, 291-320 (2005).
13. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical ompounds and drugs. Exp. Dermatol. 9(3), 165-169 (2000). (Pubitemid 30255378)
14. Osterwalder U, Herzog B. Chemistry and properties of organic and inorganic UV filters In: Clinical Guide to Sunscreens and Photoprotection. Lim HW Draelos ZW (Eds). Informa Healthcare, New York, NY, USA, 11-38 (2009).
15. Nash JF. Systemic effects of topically applied sunscreen ingredients, In: Clinical Guide To Sunscreens and Photoprotection. Lim HW, Draelos ZD (Eds). Informa Healthcare, New York, NY, USA, 139-154 (2009).
16. Rogiers V, Pauwels M. Safety Assessment of Cosmetics in Europe, Current Problems in Dermatology. S Karger AG, Basel, Switzerland (2008).
17. Herzog B, Mendrok C, Mongiat S, et al. The sunscreen simulator: a formulators tool to predict SPF and UVA parameters. SÖFW J. 129, 25-36 (2003).
18. Ferrero L, Pissavini M, Marguerie S, Zastrow L. Efficiency of a continuous height distribution model of sunscreen film geometry to predict a realistic sun protection factor. J. Cosmet. Sci. 54, 463-481 (2003). (Pubitemid 37524293)
19. Herzog B, Mongiat S, Quass K, et al. Prediction of sun protection factors and UV-A parameters by using a calibrated step film model. J. Pharm. Sci. 93, 1780-1795 (2004). (Pubitemid 38828278)
20. Herzog B. Models for the calculation of sun protection factors and parameters characterizing the UVA protection ability of cosmetic sunscreens. In: Colloids in Cosmetics and Personal Care. Tadros TF (Ed.). Wiley-VCH, Weinheim, Germany, 275-305 (2008).
21. Moyal D. How to measure UVA protection afforded by sunscreen products. Expert Rev. Dermatol. 3(3), 307-313 (2008).
22. Osterwalder U, Herzog B. Sun protection factors: world wide confusion. Br. J. Dermatol. 161(Suppl. 3), 13-24 (2009).
23. US Food and Drug Administration. 21 CFR part 201, revised effectiveness determination; sunscreen drug products for over-the-counter human use. Fed. Regist. 76(117), 35672-35678 (2011).
24. Chardon A, Moyal D, Horseau C. Persistent pigment darkening response as a method for evaluation of ultraviolet A protection assays In: Sunscreens: Devolopment, Evaluation, and Regulatory Aspects. Lowe NJ, Shaath NA, Pathak MA (Eds). Marcel Dekker Inc., New York, NY, USA, 559-582 (1997).
25. JCIA. Measurement standard for UVA protection efficacy. JCIA, Tokyo, Japan, 105, 9-14 (1995).
26. Boots UK limited. Measurement Of UVA:UVB Ratios According To The Boots Star Rating System. Boots UK limited (Eds). Boots, Nottingham, UK (2008).
27. Diffey BL. A method for broad-spectrum classification of sunscreens. Int. J. Cosmet. Sci. 16, 47-52 (1994).
28. Matts PJ, Alard V, Brown MW, et al. The COLIPA in vitro UVA method: a standard and reproducible measure of sunscreen UVA protection. Int. J. Cosmet. Sci. 32(1), 35-46 (2010).
29. Diffey BL. Spectral uniformity: a new index of broad spectrum (UVA) protection. Int. J. Cosmet. Sci. 31, 63-68 (2009).
30. Ruvolo E Jr, Chu M, Grossman F, Cole C, Kollias N. Diffuse reflectance spectroscopy for ultraviolet A protection factor measurement: correlation studies between in vitro and in vivo measurements, Photodermatol. Photoimmunol. Photomed. 25(6), 298-304 (2009).
31. Wang SQ, Stanfield JW, Osterwalder U. In vitro assessments of UVA protection by popular sunscreens available in the United States. J. Am. Acad. Dermatol. 59(6), 934-942 (2008).
32. Osterwalder U, Herzog B, The long way towards the ideal sunscreen - where we stand and what still needs to be done. Photochem. Photobiol. Sci. 9, 470-481 (2010).
33. Diffey BL. The need for sunscreens with broad spectrum protection. In: Biological Responses to Ultraviolet A Radiation. A Symposium on UV-A Radiation. Urbach F (Ed.). Valdenmar Publication Co, San Antonio, TX, USA, 321-328 (1991).
34. Fourtanier A, Moyal D, Maccario J, et al. measurement of sunscreen immune protection factors in humans: a consensus paper. J. Invest. Dermatol. 125, 403-409 (2005).
35. Holick M, Jenkins M. The UV Advantage - The Medical Breakthrough That Shows How To Harness The Power Of The Sun For Your Health. Ibooks, New York, NY, USA (2004).
36. Sayre RM, Dowdy JC. Darkness at noon: sunscreens and vitamin D3. Photodermatol. Photoimmunol. Photomed. 83, 459-463 (2007).
37. Diffey BL. Modelling the seasonal variation of vitamin D due to sun exposure. Br. J. Dermatol. 162(6), 1342-1348 (2010).
38. Food and Drug Administration. Sunscreen drug products for over-the-counter human use; proposed amendment of final monograph; proposed rule. Fed. Regist. 72(165) 49070-49122 (2007).
39. Zastrow L, Ferrero L, Herrling T, Groth N. Integrated sun protection factor based on free radicals generated by UV irradiation. Skin Pharmacol. Physiol. 17, 219-231 (2004). (Pubitemid 39370253)
40. Herrling T, Jung K, Chatelain E, Langenauer M. Radical skin/sun protection factor RSF - protection against UV-induced free radicals. SÖFW J. 132, 7-24 (2006).
41. Osterwalder U, Jung K, Seifert M, Herrling T. Importance of UVA sun protection: a comparative analysis of different quality control methods, SÖFW J. 161(S3), 13-24 (2009).
42. COLIPA. UV-A Guideline: Method for the In Vitro Determination of UVA Protection Provided by Sunscreen Products. The European Cosmetic Toiletry and Perfumery Association COLIPA. Rue de la Loi 223/2, B-1040, Bruxelles, Belguim. 1-20 (2007).
43. ISO. Determination of Sunscreen UVA Protection In Vitro, Draft International Standard. International Organization for Standardization ISO, Geneva, Switzerland, ISO/DIS 24443 (2010).
44. BASF sunscreen simulator www.basf.com/sunscreen-simulator
45. CDER. Guidance for industry, enforcement policy - OTC sunscreen drug products marketed without an approved application, draft guidance. Pages 35665-35668 www.gpo.gov/fdsys/pkg/FR-2011-06-17/pdf/2011-14767.pdf
46. CIE. UVA protection and sunscreens, technical report. CIE 186 (2010) www.cie.co.at